METTL3 and acute myeloid leukemia: METTL3 on the other hand is a critical player acute myeloid leukemia (AML) [75], which has led to the development of METTL3 inhibitors, some of which are undergoing Phase 1 clinical trials (Identifier: NCT05584111).